Aethlon Medical, Inc. (AEMD)
USD 0.35
(-4.54%)
USD 0.35
(-4.54%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 12.27 Million USD | -2.68% |
| 2023 | 12.61 Million USD | 17.73% |
| 2022 | 10.71 Million USD | 25.31% |
| 2021 | 8.55 Million USD | 22.57% |
| 2020 | 6.97 Million USD | 12.0% |
| 2019 | 6.22 Million USD | 13.5% |
| 2018 | 5.48 Million USD | -25.78% |
| 2017 | 7.39 Million USD | 40.28% |
| 2016 | 5.27 Million USD | -27.81% |
| 2015 | 7.3 Million USD | -50.1% |
| 2014 | 14.63 Million USD | 193.24% |
| 2013 | 4.98 Million USD | 11.53% |
| 2012 | 4.47 Million USD | -1.82% |
| 2011 | 4.55 Million USD | 59.96% |
| 2010 | 2.84 Million USD | -2.54% |
| 2009 | 2.92 Million USD | 1.06% |
| 2008 | 2.89 Million USD | 38.78% |
| 2007 | 2.08 Million USD | -0.51% |
| 2006 | 2.09 Million USD | -4.05% |
| 2005 | 2.18 Million USD | 119.31% |
| 2004 | 995.54 Thousand USD | -39.19% |
| 2003 | 1.63 Million USD | -27.97% |
| 2002 | 2.27 Million USD | 8.51% |
| 2001 | 2.09 Million USD | 135.44% |
| 2000 | 889.69 Thousand USD | 3537.63% |
| 1999 | 24.45 Thousand USD | 579.58% |
| 1998 | 3599.00 USD | 134.62% |
| 1997 | 1534.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.17 Million USD | -6.83% |
| 2024 Q1 | 3.4 Million USD | 11.66% |
| 2024 Q4 | 2.4 Million USD | -32.71% |
| 2024 FY | 12.27 Million USD | -2.68% |
| 2024 Q3 | 3.56 Million USD | 12.34% |
| 2023 Q3 | 2.84 Million USD | -25.15% |
| 2023 Q1 | 2.9 Million USD | -23.5% |
| 2023 Q2 | 3.8 Million USD | 31.02% |
| 2023 FY | 12.61 Million USD | 17.73% |
| 2023 Q4 | 3.05 Million USD | 7.1% |
| 2022 FY | 10.71 Million USD | 25.31% |
| 2022 Q1 | 2.23 Million USD | -2.98% |
| 2022 Q2 | 2.14 Million USD | -4.02% |
| 2022 Q4 | 3.79 Million USD | 49.26% |
| 2022 Q3 | 2.54 Million USD | 18.89% |
| 2021 FY | 8.55 Million USD | 22.57% |
| 2021 Q2 | 1.77 Million USD | 25.59% |
| 2021 Q4 | 2.29 Million USD | -25.1% |
| 2021 Q3 | 3.06 Million USD | 73.27% |
| 2021 Q1 | 1.41 Million USD | -29.19% |
| 2020 Q4 | 1.99 Million USD | 61.38% |
| 2020 Q1 | 2.04 Million USD | 22.28% |
| 2020 FY | 6.97 Million USD | 12.0% |
| 2020 Q2 | 1.7 Million USD | -16.47% |
| 2020 Q3 | 1.23 Million USD | -27.68% |
| 2019 Q1 | 1.24 Million USD | -7.35% |
| 2019 Q2 | 1.34 Million USD | 8.02% |
| 2019 Q3 | 1.96 Million USD | 45.8% |
| 2019 Q4 | 1.67 Million USD | -14.92% |
| 2019 FY | 6.22 Million USD | 13.5% |
| 2018 FY | 5.48 Million USD | -25.78% |
| 2018 Q3 | 1.23 Million USD | -0.65% |
| 2018 Q2 | 1.24 Million USD | -24.77% |
| 2018 Q1 | 1.65 Million USD | 10.15% |
| 2018 Q4 | 1.34 Million USD | 8.68% |
| 2017 Q4 | 1.5 Million USD | 27.82% |
| 2017 FY | 7.39 Million USD | 40.28% |
| 2017 Q3 | 1.17 Million USD | -54.98% |
| 2017 Q2 | 2.61 Million USD | 24.54% |
| 2017 Q1 | 2.09 Million USD | 62.58% |
| 2016 FY | 5.27 Million USD | -27.81% |
| 2016 Q3 | 1.38 Million USD | 5.52% |
| 2016 Q2 | 1.31 Million USD | 2.36% |
| 2016 Q4 | 1.29 Million USD | -6.8% |
| 2016 Q1 | 1.28 Million USD | 30.84% |
| 2015 Q4 | 980.22 Thousand USD | -34.07% |
| 2015 FY | 7.3 Million USD | -50.1% |
| 2015 Q1 | 3.68 Million USD | -54.59% |
| 2015 Q2 | 1.28 Million USD | -65.05% |
| 2015 Q3 | 1.48 Million USD | 15.33% |
| 2014 Q1 | 393.05 Thousand USD | -87.15% |
| 2014 Q2 | 3.88 Million USD | 888.19% |
| 2014 Q3 | 2.23 Million USD | -42.57% |
| 2014 Q4 | 8.12 Million USD | 264.23% |
| 2014 FY | 14.63 Million USD | 193.24% |
| 2013 Q4 | 3.05 Million USD | 1343.28% |
| 2013 FY | 4.98 Million USD | 11.53% |
| 2013 Q1 | 1.2 Million USD | -4.1% |
| 2013 Q2 | 1.59 Million USD | 32.26% |
| 2013 Q3 | 211.92 Thousand USD | -86.73% |
| 2012 FY | 4.47 Million USD | -1.82% |
| 2012 Q2 | 882.95 Thousand USD | -14.48% |
| 2012 Q1 | 1.03 Million USD | 10.02% |
| 2012 Q3 | 1.29 Million USD | 47.16% |
| 2012 Q4 | 1.25 Million USD | -3.1% |
| 2011 Q4 | 938.42 Thousand USD | -10.34% |
| 2011 Q1 | 1.16 Million USD | 76.45% |
| 2011 FY | 4.55 Million USD | 59.96% |
| 2011 Q2 | 1.4 Million USD | 21.28% |
| 2011 Q3 | 1.04 Million USD | -25.75% |
| 2010 Q3 | 715.97 Thousand USD | -10.26% |
| 2010 Q4 | 658.71 Thousand USD | -8.0% |
| 2010 Q1 | 641.95 Thousand USD | -8.24% |
| 2010 Q2 | 797.87 Thousand USD | 24.29% |
| 2010 FY | 2.84 Million USD | -2.54% |
| 2009 Q2 | 732.65 Thousand USD | 17.48% |
| 2009 Q1 | 623.65 Thousand USD | -22.46% |
| 2009 Q3 | 867.36 Thousand USD | 18.39% |
| 2009 Q4 | 699.56 Thousand USD | -19.35% |
| 2009 FY | 2.92 Million USD | 1.06% |
| 2008 Q1 | 871.27 Thousand USD | 50.26% |
| 2008 Q2 | 690.02 Thousand USD | -20.8% |
| 2008 Q3 | 526.97 Thousand USD | -23.63% |
| 2008 FY | 2.89 Million USD | 38.78% |
| 2008 Q4 | 804.31 Thousand USD | 52.63% |
| 2007 Q4 | 579.82 Thousand USD | 24.7% |
| 2007 FY | 2.08 Million USD | -0.51% |
| 2007 Q3 | 464.99 Thousand USD | -13.08% |
| 2007 Q2 | 534.94 Thousand USD | 6.6% |
| 2007 Q1 | 501.83 Thousand USD | 61.12% |
| 2006 Q1 | 735.06 Thousand USD | 19.88% |
| 2006 FY | 2.09 Million USD | -4.05% |
| 2006 Q4 | 311.47 Thousand USD | -36.95% |
| 2006 Q3 | 494.01 Thousand USD | -10.89% |
| 2006 Q2 | 554.38 Thousand USD | -24.58% |
| 2005 Q1 | 458.37 Thousand USD | 50.26% |
| 2005 FY | 2.18 Million USD | 119.31% |
| 2005 Q2 | 561.94 Thousand USD | 22.6% |
| 2005 Q3 | 549.9 Thousand USD | -2.14% |
| 2005 Q4 | 613.15 Thousand USD | 11.5% |
| 2004 FY | 995.54 Thousand USD | -39.19% |
| 2004 Q3 | 188.68 Thousand USD | -28.84% |
| 2004 Q1 | 188.41 Thousand USD | -67.04% |
| 2004 Q2 | 265.13 Thousand USD | 40.72% |
| 2004 Q4 | 305.04 Thousand USD | 61.67% |
| 2003 FY | 1.63 Million USD | -27.97% |
| 2003 Q4 | 571.61 Thousand USD | 77.36% |
| 2003 Q2 | 476.29 Thousand USD | 50.0% |
| 2003 Q3 | 322.29 Thousand USD | -32.33% |
| 2003 Q1 | 317.52 Thousand USD | -66.04% |
| 2002 Q4 | 934.94 Thousand USD | 131.16% |
| 2002 Q3 | 404.45 Thousand USD | -6.39% |
| 2002 Q2 | 432.05 Thousand USD | -14.65% |
| 2002 Q1 | 506.19 Thousand USD | -47.77% |
| 2002 FY | 2.27 Million USD | 8.51% |
| 2001 Q1 | 332.9 Thousand USD | 129.55% |
| 2001 Q4 | 969.24 Thousand USD | 124.68% |
| 2001 FY | 2.09 Million USD | 135.44% |
| 2001 Q3 | 431.38 Thousand USD | 19.45% |
| 2001 Q2 | 361.14 Thousand USD | 8.48% |
| 2000 Q2 | 252.76 Thousand USD | 42.45% |
| 2000 Q4 | 145.02 Thousand USD | -53.88% |
| 2000 Q3 | 314.45 Thousand USD | 24.4% |
| 2000 Q1 | 177.44 Thousand USD | 0.0% |
| 2000 FY | 889.69 Thousand USD | 3537.63% |
| 1999 FY | 24.45 Thousand USD | 579.58% |
| 1998 FY | 3599.00 USD | 134.62% |
| 1997 FY | 1534.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -9.386% |
| Cerus Corporation | 143.15 Million USD | 91.424% |
| OrthoPediatrics Corp. | 137.01 Million USD | 91.04% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -8.068% |
| Talis Biomedical Corporation | 67.18 Million USD | 81.726% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 50.784% |
| Inogen, Inc. | 236.08 Million USD | 94.8% |
| Spectral AI, Inc. | 20.86 Million USD | 41.155% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 78.075% |
| CVRx, Inc. | 76.14 Million USD | 83.876% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -248.002% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 1.693% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.16% |
| Venus Concept Inc. | 80.47 Million USD | 84.744% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 78.3% |
| Bioventus Inc. | 409.91 Million USD | 97.005% |
| BrainsWay Ltd. | 28.01 Million USD | 56.18% |
| Envoy Medical, Inc. | 17.89 Million USD | 31.403% |
| electroCore, Inc. | 32.03 Million USD | 61.67% |
| IceCure Medical Ltd | 16.87 Million USD | 27.249% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 71.065% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 30.372% |
| MaxCyte, Inc. | 84.84 Million USD | 85.529% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 1.082% |
| Nexalin Technology, Inc. | 5.78 Million USD | -112.364% |
| PAVmed Inc | 64.82 Million USD | 81.061% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 75.963% |
| RxSight, Inc. | 103.85 Million USD | 88.178% |
| Sight Sciences, Inc. | 126.44 Million USD | 90.291% |
| SI-BONE, Inc. | 156.35 Million USD | 92.147% |
| TELA Bio, Inc. | 84.18 Million USD | 85.416% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 82.475% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 93.963% |
| LivaNova PLC | 843.54 Million USD | 98.545% |
| 908 Devices Inc. | 68.08 Million USD | 81.966% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.461% |
| Nemaura Medical Inc. | 7.13 Million USD | -71.983% |
| NeuroPace, Inc. | 75.29 Million USD | 83.694% |
| LENSAR, Inc. | 33.33 Million USD | 63.17% |
| Apyx Medical Corporation | 51.01 Million USD | 75.935% |
| Cutera, Inc. | 197.72 Million USD | 93.791% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 50.456% |
| BioSig Technologies, Inc. | 28.53 Million USD | 56.966% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 93.588% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 65.953% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.532% |
| Axonics, Inc. | 270.2 Million USD | 95.456% |
| Outset Medical, Inc. | 198.77 Million USD | 93.823% |
| IRIDEX Corporation | 31.81 Million USD | 61.408% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.187% |
| IRadimed Corporation | 30.12 Million USD | 59.242% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -43.9% |
| INVO Bioscience, Inc. | 7.85 Million USD | -56.336% |
| Telesis Bio, Inc. | 63.48 Million USD | 80.662% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 87.53% |
| Varex Imaging Corporation | 224.8 Million USD | 94.538% |
| Quipt Home Medical Corp. | 148.66 Million USD | 91.742% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -4.73% |
| Pulmonx Corporation | 112.68 Million USD | 89.105% |
| Dynatronics Corporation | 9.9 Million USD | -23.915% |
| Modular Medical, Inc. | 17.52 Million USD | 29.959% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 39.181% |
| Semler Scientific, Inc. | 38.94 Million USD | 68.474% |
| InMode Ltd. | 215.68 Million USD | 94.308% |
| Bruker Corporation | 1.07 Billion USD | 98.859% |
| Cytosorbents Corporation | 48.33 Million USD | 74.6% |
| DexCom, Inc. | 1.69 Billion USD | 99.274% |
| Align Technology, Inc. | 2.07 Billion USD | 99.409% |
| Viveve Medical, Inc. | 22.17 Million USD | 44.629% |
| ZimVie Inc. | 275.12 Million USD | 95.537% |
| Movano Inc. | 29.69 Million USD | 58.648% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 91.056% |
| Nexalin Technology, Inc. | 5.78 Million USD | -112.364% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -248.002% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.957% |
| Profound Medical Corp. | 33.6 Million USD | 63.463% |
| Insulet Corporation | 939.9 Million USD | 98.694% |
| enVVeno Medical Corporation | 25.23 Million USD | 51.353% |
| Surmodics, Inc. | 98.69 Million USD | 87.56% |
| iCAD, Inc. | 22.22 Million USD | 44.758% |
| Nuwellis, Inc. | 22.61 Million USD | 45.706% |
| Biotricity, Inc. | 17.18 Million USD | 28.555% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.247% |
| InspireMD, Inc. | 22.95 Million USD | 46.503% |
| PAVmed Inc. | 64.82 Million USD | 81.061% |
| BIOLASE, Inc. | 34.66 Million USD | 64.578% |
| Beyond Air, Inc. | 61.7 Million USD | 80.101% |
| FONAR Corporation | 28.6 Million USD | 57.079% |
| AxoGen, Inc. | 149.33 Million USD | 91.779% |
| Vivani Medical, Inc. | 26.96 Million USD | 54.469% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 93.067% |
| Inari Medical, Inc. | 448.59 Million USD | 97.263% |
| UFP Technologies, Inc. | 58.08 Million USD | 78.864% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -149.158% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -94.317% |
| Tenon Medical, Inc. | 16.96 Million USD | 27.643% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -66.069% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 72.162% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.861% |
| Sintx Technologies, Inc. | 15.2 Million USD | 19.232% |
| NanoVibronix, Inc. | 4.97 Million USD | -146.883% |
| Quanterix Corporation | 118.1 Million USD | 89.604% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -4.73% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 14.987% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 96.873% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.284% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 56.253% |
| NeuroMetrix, Inc. | 11.09 Million USD | -10.619% |
| Hyperfine, Inc. | 52.87 Million USD | 76.779% |
| Establishment Labs Holdings Inc. | 172 Million USD | 92.862% |
| Biomerica, Inc. | 6.97 Million USD | -75.946% |
| Bone Biologics Corporation | 9.42 Million USD | -30.22% |
| AVITA Medical, Inc. | 80.77 Million USD | 84.801% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -19.069% |
| Silk Road Medical, Inc | 186.35 Million USD | 93.412% |